Clinical Trial Update: A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NLY01 in early Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NLY01

Snippet

Sponsor: Neuraly, Inc. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED